Editorial: intravenous to subcutaneous vedolizumab-switch without glitch!
Aliment Pharmacol Ther
; 56(2): 349-350, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35748843
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
Limits:
Humans
Language:
En
Journal:
Aliment Pharmacol Ther
Journal subject:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2022
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom